New Deal
Yi Shi
Managing Director at LILLY ASIA VENTURES
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Legend Biotech Corporation
Lilly Asia Ventures
£121m
13 dealmakers
Connect Biopharma
Ra Capital Management
£87m
16 dealmakers
INVENTISBIO
Hillhouse Capital Group
£115m
Gracell Biotechnologies
King Star Med
£76m
10 dealmakers
Carsgen Therapeutics
Loyal Valley Capital
£143m
4 dealmakers
Dmed Biopharmaceutical
Fidelity Management & Research Company
£74m
8 dealmakers
Abbisko Therapeutics
Sage Partners
£90m
12 dealmakers
Elpiscience Biopharmaceutical
Cormorant Asset Management
Nikang Therapeutics
Surveyor Capital
£141m
29 dealmakers
SYNTHEKINE
Janus Henderson Investors
£75m
Insilico Medicine
Formica Capital
£183m
18 dealmakers
Genesis Medtech
Trustar Capital (ex Citic Capital Partners)
value n/a
Cincor Pharma
Bvf Partners
£104m
19 dealmakers
SHOUTI
Casdin Capital
£72m
20 dealmakers
Abogen Biosciences
Invesco Asset Management
£520m
28 dealmakers
CLINCHOICE
Legend Capital
£123m
5 dealmakers